From: Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation
Baseline (mean ± SD) | Post-Tx (mean ± SD) | P = a | ||
---|---|---|---|---|
Whole Series | BCVA (logMAR) | 1.23 ± 0.56 | 0.87 ± 0.41 | 0.014 |
(n = 19) | CRT (μm) | 404.0 ± 131.7 | 306.1 ± 112.0 | 0.0002 |
Subgroups | ||||
Naïve Group | BCVA (logMAR) | 1.32 ± 0.58 | 0.92 ± 0.47 | 0.047 |
(n = 11) | CRT (μm) | 436.6 ± 96.6 | 298.6 ± 87.3 | 0.003 |
Pretreatment Group | BCVA (logMAR) | 1.09 ± 0.54 | 0.78 ± 0.33 | 0.173 |
(n = 8) | CRT (μm) | 359.1 ± 165.2 | 316.5 ± 145.4 | 0.018 |